According to FDA labeling, these medications are indicated for improving glycemic control in adults with type 2 diabetes and, in higher doses for certain formulations, for chronic weight management in adults with obesity or overweight with at least one weight-related comorbidity
Antiinvasive activity of niacin and trigonelline against cancer cells
The total cost difference between brand-name Ozempic and compounded alternatives over 18 months of treatment is approximately $13,000, making alternative options financially critical for most people
PTSD, complex trauma, EMDR-informed care
The bottom line Since the earliest days of GLP-1s with exenatide in 2005, through the past two decades to Ozempic and Mounjaro, the field has come a long way and will continue to evolve